The listings featured on this site are from companies from which this site receives compensation. This influences where, how and in what order such listings appear on this site.
Last Updated: Jun 2026
June 11, 2026
Reported effects aren't the same as proven results. Why expectations for NAD+ and similar therapies should stay modest, why timelines are uncertain, and why ongoing clinician oversight matters.
June 11, 2026
An honest overview of NAD+, metformin, low-dose naltrexone, rapamycin, and peptides—what each is, its FDA status, and how strong (or weak) the human evidence really is.
June 11, 2026
A plain-language guide to what "advanced wellness" actually covers, what the evidence does and doesn't show for NAD+ and related therapies, and why clinician oversight matters.
Learn more about how comparetreatments.com rankings are determined.
